First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

NCT01554085 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
78
Enrollment
INDUSTRY
Sponsor class

Stopped ALS-2158 showed insufficient antiviral activity to warrant proceeding with further clinical development.

Conditions

Interventions

Sponsor

Alios Biopharma Inc.

Collaborators